What Are GLP-1 Medications? A Complete Beginner's Guide
GLP-1 medicines are prescription treatments that act on hormone pathways involved in blood glucose control and appetite. Some are authorised for type 2 diabetes, some for weight management, and the brand and active ingredient determine the approved use. They are not ordinary supplements or a general solution for cosmetic weight loss.
Names such as Wegovy, Ozempic and Mounjaro can be confusing because some share an ingredient while others act on more than one hormone receptor. This UK guide explains the terminology, what treatment involves and why nutrition remains important when appetite changes.
What does GLP-1 stand for?
GLP-1 means glucagon-like peptide-1, a hormone involved in the body’s response to food. A GLP-1 receptor agonist acts at that hormone’s receptor. Medicines in this group can influence appetite and glucose regulation, and may slow stomach emptying.
Tirzepatide, the ingredient in Mounjaro, acts at both GLP-1 and GIP receptors. It is often grouped with GLP-1 medicines in everyday discussion, although its dual action is an important distinction. Our guide to how these medicines work explains the mechanisms in plain language.
Common names and their differences
Name
Active ingredient
Important distinction
Wegovy
Semaglutide
A brand authorised for weight management in defined circumstances.
Ozempic
Semaglutide
A diabetes medicine; sharing an ingredient with Wegovy does not make the brands interchangeable.
Mounjaro
Tirzepatide
A dual GIP/GLP-1 medicine authorised for type 2 diabetes and weight management in defined circumstances.
Other GLP-1 medicines
Ingredients and brands vary
Check the individual product information and licensed use.
Licensing, clinical suitability and NHS availability are separate questions. A medicine being licensed does not mean every person qualifies or that access is identical across the UK. Your prescriber should explain the relevant pathway and current criteria.
Who assesses whether treatment is appropriate?
A qualified prescriber needs to review your health history, medicines, relevant measurements and treatment goals. That assessment includes possible benefits, risks and practical follow-up. It is more than choosing a brand from a comparison chart.
Tell the prescriber about existing conditions, pregnancy plans and all medicines or supplements. If you already use a treatment for diabetes, changes may require monitoring and professional adjustment. Do not independently reduce insulin or other treatment when starting a new medicine.
What can change during treatment?
Some people notice less hunger or feel full after smaller amounts. That can make eating patterns different from before. It does not mean food is no longer important or that the smallest possible intake is the best outcome.
A smaller appetite can create practical problems: forgetting meals, leaving protein foods uneaten or drinking less because the routine around meals has changed. Our nutrition guide during GLP-1 treatment explains how to keep meals useful and manageable.
Regular follow-up matters because response and tolerability vary. Do not increase a dose faster, combine medicines or change brands based on another person’s experience. Follow your own prescription and the leaflet supplied with the medicine.
Side effects and when to ask for help
Digestive effects can include nausea, vomiting, diarrhoea, constipation or abdominal discomfort. Persistent or worsening problems need review by the treatment team. Contact them promptly if you cannot maintain food or fluid intake or feel lightheaded and dehydrated.
Severe persistent abdominal pain, particularly if it spreads to the back or occurs with vomiting, needs urgent medical attention because pancreatitis is a recognised serious risk. Do not assume severe symptoms are simply evidence that the medicine is working.
Check the specific medicine leaflet for the complete side-effect and urgent-action instructions. Our hydration guide covers everyday drinking routines and signs that need help.
Pregnancy, contraception and procedures
These medicines are not used during pregnancy or breastfeeding. Pregnancy planning requires medicine-specific advice and an appropriate stopping interval from the prescriber. Do not rely on a general internet timetable for your own treatment.
For people using oral contraception with tirzepatide, additional precautions are needed after starting and after dose increases. Ask the prescriber or pharmacist for the current instructions. Also tell the team before an operation, deep sedation or anaesthesia because slowed stomach emptying can affect procedural planning.
Where should prescription medicines come from?
Use a legitimate pharmacy with a prescription following an appropriate clinical consultation. Avoid social-media sellers or products supplied without a proper assessment. The appearance of a pen, packaging or testimonial cannot establish that an unregulated product is genuine.
A supplement claiming to “boost GLP-1” is not an equivalent replacement for a prescribed receptor agonist. Nutrient supplements have different purposes and should be reviewed as part of the complete routine, as explained in our supplements and GLP-1 guide.
Questions to take to your prescriber
Which condition is this medicine intended to treat in my case?
What follow-up and monitoring will I receive?
Which side effects need a call, urgent advice or emergency care?
How should I manage eating or drinking difficulties?
Do my other medicines, pregnancy plans or procedures change the plan?
Frequently asked questions
Are GLP-1 medicines the same as insulin?
No. They are different treatments. If you use insulin, any adjustment must be managed by your clinical team.
Are all GLP-1 medicines weight-loss medicines?
No. Approved uses differ by ingredient and brand. Ozempic and Wegovy share semaglutide but have different licensed uses.
Is Mounjaro a GLP-1 medicine?
It acts at GLP-1 and GIP receptors. That dual action distinguishes tirzepatide from a GLP-1-only receptor agonist.
Can supplements replace treatment?
No. Ordinary food supplements are not interchangeable with prescription medicines.
Do I still need to plan meals?
Yes. Reduced appetite can make nutritional planning more important. Start with manageable meals and seek support if intake remains poor.
About this guide: Published by iLoveVits, a food-supplement retailer. This is general educational information. References are linked for checking the underlying evidence; ingredient research does not establish results for an iLoveVits finished product. Individual medical advice takes priority.
What Are GLP-1 Medications? A Complete Beginner's Guide
GLP-1 medicines are prescription treatments that act on hormone pathways involved in blood glucose control and appetite. Some are authorised for type 2 diabetes, some for weight management, and the brand and active ingredient determine the approved use. They are not ordinary supplements or a general solution for cosmetic weight loss.
Names such as Wegovy, Ozempic and Mounjaro can be confusing because some share an ingredient while others act on more than one hormone receptor. This UK guide explains the terminology, what treatment involves and why nutrition remains important when appetite changes.
What does GLP-1 stand for?
GLP-1 means glucagon-like peptide-1, a hormone involved in the body’s response to food. A GLP-1 receptor agonist acts at that hormone’s receptor. Medicines in this group can influence appetite and glucose regulation, and may slow stomach emptying.
Tirzepatide, the ingredient in Mounjaro, acts at both GLP-1 and GIP receptors. It is often grouped with GLP-1 medicines in everyday discussion, although its dual action is an important distinction. Our guide to how these medicines work explains the mechanisms in plain language.
Common names and their differences
Licensing, clinical suitability and NHS availability are separate questions. A medicine being licensed does not mean every person qualifies or that access is identical across the UK. Your prescriber should explain the relevant pathway and current criteria.
Who assesses whether treatment is appropriate?
A qualified prescriber needs to review your health history, medicines, relevant measurements and treatment goals. That assessment includes possible benefits, risks and practical follow-up. It is more than choosing a brand from a comparison chart.
Tell the prescriber about existing conditions, pregnancy plans and all medicines or supplements. If you already use a treatment for diabetes, changes may require monitoring and professional adjustment. Do not independently reduce insulin or other treatment when starting a new medicine.
What can change during treatment?
Some people notice less hunger or feel full after smaller amounts. That can make eating patterns different from before. It does not mean food is no longer important or that the smallest possible intake is the best outcome.
A smaller appetite can create practical problems: forgetting meals, leaving protein foods uneaten or drinking less because the routine around meals has changed. Our nutrition guide during GLP-1 treatment explains how to keep meals useful and manageable.
Regular follow-up matters because response and tolerability vary. Do not increase a dose faster, combine medicines or change brands based on another person’s experience. Follow your own prescription and the leaflet supplied with the medicine.
Side effects and when to ask for help
Digestive effects can include nausea, vomiting, diarrhoea, constipation or abdominal discomfort. Persistent or worsening problems need review by the treatment team. Contact them promptly if you cannot maintain food or fluid intake or feel lightheaded and dehydrated.
Severe persistent abdominal pain, particularly if it spreads to the back or occurs with vomiting, needs urgent medical attention because pancreatitis is a recognised serious risk. Do not assume severe symptoms are simply evidence that the medicine is working.
Check the specific medicine leaflet for the complete side-effect and urgent-action instructions. Our hydration guide covers everyday drinking routines and signs that need help.
Pregnancy, contraception and procedures
These medicines are not used during pregnancy or breastfeeding. Pregnancy planning requires medicine-specific advice and an appropriate stopping interval from the prescriber. Do not rely on a general internet timetable for your own treatment.
For people using oral contraception with tirzepatide, additional precautions are needed after starting and after dose increases. Ask the prescriber or pharmacist for the current instructions. Also tell the team before an operation, deep sedation or anaesthesia because slowed stomach emptying can affect procedural planning.
Where should prescription medicines come from?
Use a legitimate pharmacy with a prescription following an appropriate clinical consultation. Avoid social-media sellers or products supplied without a proper assessment. The appearance of a pen, packaging or testimonial cannot establish that an unregulated product is genuine.
A supplement claiming to “boost GLP-1” is not an equivalent replacement for a prescribed receptor agonist. Nutrient supplements have different purposes and should be reviewed as part of the complete routine, as explained in our supplements and GLP-1 guide.
Questions to take to your prescriber
Frequently asked questions
Are GLP-1 medicines the same as insulin?
No. They are different treatments. If you use insulin, any adjustment must be managed by your clinical team.
Are all GLP-1 medicines weight-loss medicines?
No. Approved uses differ by ingredient and brand. Ozempic and Wegovy share semaglutide but have different licensed uses.
Is Mounjaro a GLP-1 medicine?
It acts at GLP-1 and GIP receptors. That dual action distinguishes tirzepatide from a GLP-1-only receptor agonist.
Can supplements replace treatment?
No. Ordinary food supplements are not interchangeable with prescription medicines.
Do I still need to plan meals?
Yes. Reduced appetite can make nutritional planning more important. Start with manageable meals and seek support if intake remains poor.
Sources
MHRA: GLP-1 medicines for weight loss and diabetes and NHS: Tirzepatide.
About this guide: Published by iLoveVits, a food-supplement retailer. This is general educational information. References are linked for checking the underlying evidence; ingredient research does not establish results for an iLoveVits finished product. Individual medical advice takes priority.